InvestorsHub Logo

duchamp

10/01/21 10:11 AM

#376868 RE: Justfactsmam #376861

The collusion to kill the company and shareholder value is overwhelming. Life can be just a little to crappy and unfair sometimes.

duchamp

Hungry_Ghost

10/01/21 10:23 AM

#376876 RE: Justfactsmam #376861

A toxic failed drug resurrected. So toxic the original company abandoned any testing on molnupiravir. Whistleblower reports warning the HHS and others are all over the web. Read them now before they are scrubbed. It sure is good to be BP in a corrupt system.

farrell90

10/01/21 1:38 PM

#376947 RE: Justfactsmam #376861

Ridgeback's Molnupiravir failed its cliniacal trial for hospitalized patients with moderate to severe covid.It was halted by Merck after the FDA asked for additional information.

https://www.empr.com/home/news/molnupiravir-merck-ridgeback-oral-antiviral-investigational-covid-19-treatment/

The current possible indications for Molnupiravir will be limited to prophylaxsis and early mild to moderate non hospitalized covid.

https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/

Brilacidin's clinical trial is for hospitalized patients with moderate to severe covid...

the trial Molnupiravir failed.

GLTA,

Farrell